Michael Zinda insider trades: Repare Therapeutics (RPTX) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Michael reports to the SEC
Open-market buys and sales
13 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 12, 2025 | RPTX | ↓ Sell | 5,611 | $1.14 | $6K | Direct | Mar 14, 2025 (2d) |
| Apr 1, 2024 | RPTX | ↓ Sell | 860 | $4.65 | $4K | Direct | Apr 1, 2024 (0d) |
| Mar 27, 2024 | RPTX | ↓ Sell | 1,350 | $4.67 | $6K | Direct | Mar 27, 2024 (0d) |
| Jun 8, 2023 | RPTX | ↓ Sell | 9,273 | $12.03 | $112K | Direct | Jun 9, 2023 (1d) |
| Jun 6, 2023 | RPTX | ↓ Sell | 1,200 | $12.04 | $14K | Direct | Jun 7, 2023 (1d) |
| Mar 15, 2022 | RPTX | ↓ Sell | 533 | $11.30 | $6K | Direct | Mar 16, 2022 (1d) |
| Nov 15, 2021 | RPTX | ↓ Sell | 20,000 | $27.33 | $547K | Direct | Nov 17, 2021 (2d) |
| Aug 16, 2021 | RPTX | ↓ Sell | 15,000 | $33.99 | $510K | Direct | Aug 20, 2021 (4d) |
| May 17, 2021 | RPTX | ↓ Sell | 15,000 | $32.71 | $491K | Direct | May 18, 2021 (1d) |
| Dec 29, 2020 | RPTX | ↓ Sell | 34,744 | $33.92 | $1.2M | Direct | Dec 30, 2020 (1d) |
| Dec 24, 2020 | RPTX | ↓ Sell | 57,979 | $33.46 | $1.9M | Direct | Dec 28, 2020 (4d) |
| Dec 21, 2020 | RPTX | ↓ Sell | 40,000 | $33.08 | $1.3M | Direct | Dec 22, 2020 (1d) |
| Dec 18, 2020 | RPTX | ↓ Sell | 17,277 | $34.94 | $604K | Direct | Dec 18, 2020 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Michael Zinda's insider trades
Michael Zinda is EVP, Chief Scientific Officer at Repare Therapeutics (RPTX). Since Dec 18, 2020, Michael has reported no open-market purchases and 13 sales worth $6.7M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include option exercises (6 filings), grants and awards (5 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RPTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.